179 related articles for article (PubMed ID: 38596681)
61. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach.
Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV
Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176
[TBL] [Abstract][Full Text] [Related]
62. Role of TGF-β in Self-Peptide Regulation of Autoimmunity.
Singh B; Krawetz MD; De Lima RM; Mukherjee R; Chaturvedi P; Lee-Chan E; Leiter EH; Summers KL
Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):11-19. PubMed ID: 28733878
[TBL] [Abstract][Full Text] [Related]
63. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
Butty V; Campbell C; Mathis D; Benoist C;
Diabetes; 2008 Sep; 57(9):2348-59. PubMed ID: 18556337
[TBL] [Abstract][Full Text] [Related]
64. Specific monoclonal antibodies against the surface of rat islet beta cells.
Konidaris C; Simonson W; Michelsen B; Papadopoulos GK
Cell Biol Int; 2002; 26(9):817-28. PubMed ID: 12377213
[TBL] [Abstract][Full Text] [Related]
65. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.
Marin-Gallen S; Clemente-Casares X; Planas R; Pujol-Autonell I; Carrascal J; Carrillo J; Ampudia R; Verdaguer J; Pujol-Borrell R; Borràs FE; Vives-Pi M
Clin Exp Immunol; 2010 May; 160(2):207-14. PubMed ID: 20030670
[TBL] [Abstract][Full Text] [Related]
66. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
Lander T; Nerl C; Held M; Standl E; Mehnert H
Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
[TBL] [Abstract][Full Text] [Related]
67. Tolerogenic Nanoparticles to Treat Islet Autoimmunity.
Neef T; Miller SD
Curr Diab Rep; 2017 Aug; 17(10):84. PubMed ID: 28791576
[TBL] [Abstract][Full Text] [Related]
68. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Pinkse GG; Tysma OH; Bergen CA; Kester MG; Ossendorp F; van Veelen PA; Keymeulen B; Pipeleers D; Drijfhout JW; Roep BO
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18425-30. PubMed ID: 16339897
[TBL] [Abstract][Full Text] [Related]
69. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
70. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
[TBL] [Abstract][Full Text] [Related]
71. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
[TBL] [Abstract][Full Text] [Related]
72. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
73. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
74. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
Front Immunol; 2021; 12():668680. PubMed ID: 34113344
[TBL] [Abstract][Full Text] [Related]
75. Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective.
Samassa F; Mallone R
Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):370-378. PubMed ID: 35777965
[TBL] [Abstract][Full Text] [Related]
76. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
77. Thymus and type 1 diabetes: an update.
Geenen V
Diabetes Res Clin Pract; 2012 Oct; 98(1):26-32. PubMed ID: 22717497
[TBL] [Abstract][Full Text] [Related]
78. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
[TBL] [Abstract][Full Text] [Related]
79. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
80. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.
Pietropaolo M; Towns R; Eisenbarth GS
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
